Nantahala Capital Management, LLC's Form 4 filing
Evoke Pharma Inc (EVOK) · filed Jan 30, 2025
- Accession no.
- 0001104659-25-007682
- Filed
- Jan 30, 2025, 6:39 PM ET
- Trade date
- Jan 28, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $179.87. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nantahala Capital Management, LLCCIK 0001472322 | 10% Owner |
| Mack DanielCIK 0001775831 | 10% Owner |
| Harkey Wilmot B.CIK 0001775952 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2025 | Common Stock | SSaleDisposed | −41 | $4.39 | −$179.87 | 148,153 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.